RU2001105385A - DELIVERY OF ACTIVE MEANS TO LIGHT AND THROUGH LIGHT - Google Patents
DELIVERY OF ACTIVE MEANS TO LIGHT AND THROUGH LIGHTInfo
- Publication number
- RU2001105385A RU2001105385A RU2001105385/14A RU2001105385A RU2001105385A RU 2001105385 A RU2001105385 A RU 2001105385A RU 2001105385/14 A RU2001105385/14 A RU 2001105385/14A RU 2001105385 A RU2001105385 A RU 2001105385A RU 2001105385 A RU2001105385 A RU 2001105385A
- Authority
- RU
- Russia
- Prior art keywords
- alkyl
- alkenyl
- igf
- insulin
- heparin
- Prior art date
Links
- 102000014429 Insulin-like growth factor Human genes 0.000 claims 18
- 108050003490 Insulin-like growth factor Proteins 0.000 claims 18
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 18
- 239000003795 chemical substances by application Substances 0.000 claims 15
- 229920000669 heparin Polymers 0.000 claims 14
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 13
- 125000001624 naphthyl group Chemical group 0.000 claims 12
- 229960002897 Heparin Drugs 0.000 claims 10
- ZFGMDIBRIDKWMY-PASTXAENSA-N Heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 claims 10
- 102000004877 Insulin Human genes 0.000 claims 9
- 108090001061 Insulin Proteins 0.000 claims 9
- 102000004218 Insulin-like growth factor I Human genes 0.000 claims 9
- 108090000723 Insulin-like growth factor I Proteins 0.000 claims 9
- 125000000217 alkyl group Chemical group 0.000 claims 8
- 239000000122 growth hormone Substances 0.000 claims 8
- 150000001875 compounds Chemical class 0.000 claims 7
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims 6
- 239000000969 carrier Substances 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- 102000003982 Parathyroid hormone Human genes 0.000 claims 5
- 108090000445 Parathyroid hormone Proteins 0.000 claims 5
- 125000004435 hydrogen atoms Chemical class [H]* 0.000 claims 5
- 239000003055 low molecular weight heparin Substances 0.000 claims 5
- 229960001319 parathyroid hormone Drugs 0.000 claims 5
- 239000000199 parathyroid hormone Substances 0.000 claims 5
- 125000006725 C1-C10 alkenyl group Chemical group 0.000 claims 4
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims 4
- IMZMKUWMOSJXDT-UHFFFAOYSA-N Cromoglicic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 claims 4
- HTTJABKRGRZYRN-UHFFFAOYSA-N Enoxaparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 4
- 239000002202 Polyethylene glycol Substances 0.000 claims 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims 4
- 229920001223 polyethylene glycol Polymers 0.000 claims 4
- 229960004015 Calcitonin Drugs 0.000 claims 3
- 108060001064 Calcitonin Proteins 0.000 claims 3
- 102400000113 Calcitonin Human genes 0.000 claims 3
- 229920001499 Heparinoid Polymers 0.000 claims 3
- 229940025770 Heparinoids Drugs 0.000 claims 3
- 102000014150 Interferons Human genes 0.000 claims 3
- 108010050904 Interferons Proteins 0.000 claims 3
- 108090000177 Interleukin-11 Proteins 0.000 claims 3
- 102000003815 Interleukin-11 Human genes 0.000 claims 3
- 229940074383 Interleukin-11 Drugs 0.000 claims 3
- MYPYJXKWCTUITO-LYRMYLQWSA-N VANCOMYCIN Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 claims 3
- 229960003165 Vancomycin Drugs 0.000 claims 3
- 108010059993 Vancomycin Proteins 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 3
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 3
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 claims 3
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 3
- 239000002554 heparinoid Substances 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000011780 sodium chloride Substances 0.000 claims 3
- 229960003726 vasopressin Drugs 0.000 claims 3
- PMATZTZNYRCHOR-CGLBZJNRSA-N (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17 Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 claims 2
- 102100006435 CSF3 Human genes 0.000 claims 2
- 229940119017 Cyclosporine Drugs 0.000 claims 2
- 108010036949 Cyclosporine Proteins 0.000 claims 2
- 229960000958 Deferoxamine Drugs 0.000 claims 2
- 102000003951 Erythropoietin Human genes 0.000 claims 2
- 108090000394 Erythropoietin Proteins 0.000 claims 2
- 108010029961 Filgrastim Proteins 0.000 claims 2
- 229960004177 Filgrastim Drugs 0.000 claims 2
- 108010084340 Gonadotropin-Releasing Hormone Proteins 0.000 claims 2
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 claims 2
- 102000003996 Interferon beta Human genes 0.000 claims 2
- 108090000467 Interferon beta Proteins 0.000 claims 2
- 102000006992 Interferon-alpha Human genes 0.000 claims 2
- 108010047761 Interferon-alpha Proteins 0.000 claims 2
- 102000008070 Interferon-gamma Human genes 0.000 claims 2
- 108010074328 Interferon-gamma Proteins 0.000 claims 2
- 229940047124 Interferons Drugs 0.000 claims 2
- 102000000589 Interleukin-1 Human genes 0.000 claims 2
- 108010002352 Interleukin-1 Proteins 0.000 claims 2
- 210000004072 Lung Anatomy 0.000 claims 2
- UBQYURCVBFRUQT-UHFFFAOYSA-N N-benzoyl-Ferrioxamine B Chemical compound CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN UBQYURCVBFRUQT-UHFFFAOYSA-N 0.000 claims 2
- 101710008205 OXT Proteins 0.000 claims 2
- 102100017240 OXT Human genes 0.000 claims 2
- 229960001723 Oxytocin Drugs 0.000 claims 2
- XNOPRXBHLZRZKH-DSZYJQQASA-N Oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 claims 2
- 229940082622 Prostaglandin cardiac therapy preparations Drugs 0.000 claims 2
- 229940077717 Prostaglandin drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) Drugs 0.000 claims 2
- 102000005157 Somatostatin Human genes 0.000 claims 2
- 229960000553 Somatostatin Drugs 0.000 claims 2
- 108010056088 Somatostatin Proteins 0.000 claims 2
- 102000036902 Thrombopoietin Human genes 0.000 claims 2
- 108010041111 Thrombopoietin Proteins 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000004946 alkenylalkyl group Chemical group 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000005038 alkynylalkyl group Chemical group 0.000 claims 2
- 239000003429 antifungal agent Substances 0.000 claims 2
- 239000004599 antimicrobial Substances 0.000 claims 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims 2
- 108010006025 bovine growth hormone Proteins 0.000 claims 2
- 229960001265 ciclosporin Drugs 0.000 claims 2
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 claims 2
- 229940042399 direct acting antivirals Protease inhibitors Drugs 0.000 claims 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims 2
- 229940105423 erythropoietin Drugs 0.000 claims 2
- 229940044627 gamma-interferon Drugs 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 101700057139 oxyT Proteins 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 229940094443 oxytocics Prostaglandins Drugs 0.000 claims 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims 2
- 150000003180 prostaglandins Chemical class 0.000 claims 2
- 239000003488 releasing hormone Substances 0.000 claims 2
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 claims 2
- 125000004434 sulfur atoms Chemical group 0.000 claims 2
- 102000002723 Atrial Natriuretic Factor Human genes 0.000 claims 1
- 101800001288 Atrial natriuretic factor Proteins 0.000 claims 1
- 101800001866 Atrial natriuretic peptide Proteins 0.000 claims 1
- 229920002567 Chondroitin Polymers 0.000 claims 1
- 229920000045 Dermatan sulfate Polymers 0.000 claims 1
- VSHJAJRPRRNBEK-LMVCGNDWSA-N Eel calcitonin Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CS)[C@@H](C)O)C(C)C)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C1=CN=CN1 VSHJAJRPRRNBEK-LMVCGNDWSA-N 0.000 claims 1
- 229940028334 Follicle Stimulating Hormone Drugs 0.000 claims 1
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 claims 1
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 claims 1
- 102000004547 Glucosylceramidase Human genes 0.000 claims 1
- 108010017544 Glucosylceramidase Proteins 0.000 claims 1
- 229920002683 Glycosaminoglycan Polymers 0.000 claims 1
- 229940088597 Hormone Drugs 0.000 claims 1
- 108060006375 POMC Proteins 0.000 claims 1
- 241000282320 Panthera leo Species 0.000 claims 1
- BBBFJLBPOGFECG-UHFFFAOYSA-N Salmon calcitonin Chemical compound C=1N=CNC=1CC(C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(C)O)C(=O)NC(CC=1C=CC(O)=CC=1)C(=O)N1C(CCC1)C(=O)NC(CCCNC(N)=N)C(=O)NC(C(C)O)C(=O)NC(CC(N)=O)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N1C(CCC1)C(N)=O)NC(=O)C(CC(C)C)NC(=O)C(CCC(O)=O)NC(=O)C(CCC(N)=O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C1CSSCC(N)C(=O)NC(CO)C(=O)NC(CC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)N1 BBBFJLBPOGFECG-UHFFFAOYSA-N 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical group [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 125000002877 alkyl aryl group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- 230000000111 anti-oxidant Effects 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000038129 antigens Human genes 0.000 claims 1
- 108091007172 antigens Proteins 0.000 claims 1
- 229960000070 antineoplastic Monoclonal antibodies Drugs 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 125000004429 atoms Chemical group 0.000 claims 1
- 229960003773 calcitonin (salmon synthetic) Drugs 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- -1 fragments of P TH Substances 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000004404 heteroalkyl group Chemical group 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 125000005842 heteroatoms Chemical group 0.000 claims 1
- 125000005343 heterocyclic alkyl group Chemical group 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxyl anion Chemical group [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims 1
- 229940079322 interferon Drugs 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 102000005614 monoclonal antibodies Human genes 0.000 claims 1
- 229960000060 monoclonal antibodies Drugs 0.000 claims 1
- 108010045030 monoclonal antibodies Proteins 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 1
- 239000010452 phosphate Chemical group 0.000 claims 1
- 229920005575 poly(amic acid) Polymers 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 229940120657 salmon calcitonin Drugs 0.000 claims 1
- 108010068072 salmon calcitonin Proteins 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical group [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- ODGCEQLVLXJUCC-UHFFFAOYSA-N tetrafluoroborate Chemical group F[B-](F)(F)F ODGCEQLVLXJUCC-UHFFFAOYSA-N 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
Claims (17)
где R1 представляет собой С1-С7-алкил, С3-С10-циклоалкил, циклоалкенил, арил, тиенил, фенил, нафтил, пирроло или пиридил;
R1 необязательно замещен одной или несколькими группами, С1-С7-алкил, С2-С7-алкенил, С2-С7-алкинил, С6-С10-циклоалкил, фенил, фенокси, F, Cl, BR, -ОН, -SO2, -SO3Н, -NO2, -SH, -PO3H, оксазоло, изоксазоло, алкокси формулы -OR6, -COOR7, N(R5)2, -N+(R5)3X-, или любой их комбинацией;
Y представляет собой или -SO2-;
Х представляет собой галоген, гидроксид, сульфат, тетрафтороборат или фосфат;
R2 представляет собой водород, С1-С4-алкил, С2-С4-алкенил или -(СН2)n-СООН, где n составляет от 1 до 10;
R3 представляет собой С1-С24-алкил, С2-С24-алкенил, С2-С24-алкинил, С3-С10-циклоалкил, С3-С10-циклоалкенил, фенил, нафтил, (C1-С10-алкил) фенил, (С2-С10-алкенил) фенил, (C1-C10-алкил)нафтил, (С2-С10-алкенил)нафтил, фенил(C1-С10-алкил), фенил (С2-С10-алкенил), нафтил (C1-С10-алкил) или нафтил (С2-С10-алкенил);
R3 при этом необязательно замещен С1-С4-алкилом, С2-С4- алкенилом, С1-С4-алкокси, -OН, -SH, галогеном, -NH2, -CO2R4, С3-С10-циклоалкилом, С3-С10-циклоалкенилом, гетероциклом, содержащим в кольце 3-10 атомов, где гетероатом представляет собой один или несколько атомов N, О, S или любую их комбинацию, арил, (C1-С10-алк) арил, ар (C1-C10-алкил), или любой их комбинацией;
R4 представляет собой водород, С1-С4-алкил или С2-С4-алкенил;
R5 представляет собой водород или C1-С10-алкил;
R6 представляет собой C1-С10-алкил, алкенил, алкинил, арил или циклоалкил; и
R7 представляет собой водород, C1-С10-алкил, алкенил, алкинил, арил или циклоалкил.8. The method according to p. 1, characterized in that the carrier is a compound having the formula
where R 1 represents a C 1 -C 7 -alkyl, C 3 -C 10 -cycloalkyl, cycloalkenyl, aryl, thienyl, phenyl, naphthyl, pyrrolo or pyridyl;
R 1 is optionally substituted by one or more groups, C 1 -C 7 -alkyl, C 2 -C 7 -alkenyl, C 2 -C 7 -alkynyl, C 6 -C 10 -cycloalkyl, phenyl, phenoxy, F, Cl, BR , -OH, -SO 2 , -SO 3 H, -NO 2 , -SH, -PO 3 H, oxazolo, isoxazolo, alkoxy of the formula -OR 6 , -COOR 7 , N (R 5 ) 2 , -N + ( R 5 ) 3 X - , or any combination thereof;
Y is or -SO 2 -;
X is halogen, hydroxide, sulfate, tetrafluoroborate or phosphate;
R 2 is hydrogen, C 1 -C 4 -alkyl, C 2 -C 4 -alkenyl or - (CH 2 ) n-COOH, where n is from 1 to 10;
R 3 is C 1 -C 24 alkyl, C 2 -C 24 alkenyl, C 2 -C 24 alkynyl, C 3 -C 10 cycloalkyl, C 3 -C 10 cycloalkenyl, phenyl, naphthyl, (C 1 -C 10 -alkyl) phenyl, (C 2 -C 10 -alkenyl) phenyl, (C 1 -C 10 -alkyl) naphthyl, (C 2 -C 10 -alkenyl) naphthyl, phenyl (C 1 -C 10 - alkyl), phenyl (C 2 -C 10 alkenyl), naphthyl (C 1 -C 10 alkyl) or naphthyl (C 2 -C 10 alkenyl);
R 3 is optionally substituted with C 1 -C 4 -alkyl, C 2 -C 4 -alkenyl, C 1 -C 4 -alkoxy, -OH, -SH, halogen, -NH 2 , -CO 2 R 4 , C 3 -C 10 -cycloalkyl, C 3 -C 10 -cycloalkenyl, heterocycle containing 3-10 atoms in the ring, where the hetero atom is one or more N, O, S atoms or any combination thereof, aryl, (C 1 -C 10 -alk) aryl, ap (C 1 -C 10 -alkyl), or any combination thereof;
R 4 represents hydrogen, C 1 -C 4 alkyl or C 2 -C 4 alkenyl;
R 5 represents hydrogen or C 1 -C 10 -alkyl;
R 6 is C 1 -C 10 -alkyl, alkenyl, alkynyl, aryl, or cycloalkyl; and
R 7 represents hydrogen, C 1 -C 10 -alkyl, alkenyl, alkynyl, aryl or cycloalkyl.
R8 представлен формулой
R9 представляет собой С1-С24-алкил, C2-C24-алкенил, фенил, нафтил, (C1-С10-алкил)фенил, (C1-С10-алкенил)фенил, (C1-С10-алкил) нафтил, (C1-C10-алкенил) нафтил, фенил (C1-C10-алкил), фенил (C1-С10-алкенил), нафтил (C1-С10-алкил) или нафтил (C1-С10-алкенил);
R9 необязательно замещен С1-С4-алкилом, С2-С4-алкенилом, С1-С4-алкокси, -OН, -SH, -CO2R11, циклоалкилом, циклоалкенилом, гетероциклическим алкилом, алкарилом, гетероарилом, гетероалкарилом или любой их комбинацией;
R9, необязательно, прерывается атомом кислорода, азота, серы или любой их комбинацией;
R10 представляет собой водород, С1-С4-алкил или С2-С4-алкенил; и
R11 представляет собой водород, С1-С4-алкил или С2-С4-алкенил.10. The method according to claim 1, characterized in that the carrier comprises a compound having the formula Ar-Y- (R 8 ) n -OH, where Ar is a substituted or unsubstituted phenyl or naphthyl, preferably, Ar is a substituted or unsubstituted 2 -OH-phenyl; Y is or -SO 2 -;
R 8 is represented by the formula
R 9 is C 1 -C 24 alkyl, C 2 -C 24 alkenyl, phenyl, naphthyl, (C 1 -C 10 alkyl) phenyl, (C 1 -C 10 alkenyl) phenyl, (C 1 - C 10 -alkyl) naphthyl, (C 1 -C 10 -alkenyl) naphthyl, phenyl (C 1 -C 10 -alkyl), phenyl (C 1 -C 10 -alkenyl), naphthyl (C 1 -C 10 -alkyl) or naphthyl (C 1 -C 10 -alkenyl);
R 9 is optionally substituted with C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 1 -C 4 alkoxy, —OH, —SH, —CO 2 R 11 , cycloalkyl, cycloalkenyl, heterocyclic alkyl, alkaryl, heteroaryl , heteroalkyl or any combination thereof;
R 9 is optionally interrupted by an oxygen, nitrogen, sulfur atom, or any combination thereof;
R 10 is hydrogen, C 1 -C 4 alkyl or C 2 -C 4 alkenyl; and
R 11 is hydrogen, C 1 -C 4 alkyl or C 2 -C 4 alkenyl.
и его соли.12. The method according to p. 1, characterized in that the carrier includes a compound having the formula
and its salts.
или его соль.14. The method according to p. 1, characterized in that the carrier includes a compound having the formula
or its salt.
или его соль.16. The method according to p. 1, characterized in that the carrier includes a compound having the formula
or its salt.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60/094,267 | 1998-07-27 | ||
US60/104,466 | 1998-10-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2001105385A true RU2001105385A (en) | 2002-12-20 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2002521455A5 (en) | ||
CA2338419A1 (en) | Pulmonary delivery of active agents | |
JP2003513060A5 (en) | ||
CA2369591A1 (en) | Disodium salts, monohydrate, and ethanol solvates | |
CA2421575A1 (en) | Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents | |
IL149337A (en) | Phenoxy carboxylic acid compounds and compositions for delivering active agents | |
CA2465641A1 (en) | Phenoxy amine compounds and compositions for delivering active agents | |
JP2002522413A5 (en) | ||
CA2360220C (en) | Oxadiazole compounds and compositions for delivering active agents | |
US7351741B2 (en) | Compounds and compositions for delivering active agents | |
US7138546B2 (en) | Compounds and compositions for delivering active agents | |
US6440929B1 (en) | Pulmonary delivery of active agents | |
US7495030B2 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
CA2364849A1 (en) | Compounds and compositions for delivering active agents | |
EP2272501B1 (en) | Polymorphs of sodium 4-((4-chloro-2-hydroxybenzoyl) amino) butanoate | |
AU2001273153A1 (en) | Compounds and compositions for delivering active agents | |
JP4907552B2 (en) | Gallium salt formulation | |
US20030220226A1 (en) | Compounds and compositions for delivering active agents | |
RU2001105385A (en) | DELIVERY OF ACTIVE MEANS TO LIGHT AND THROUGH LIGHT | |
RU2006140794A (en) | METHODS FOR PRODUCING Acyclovir MEDICINES | |
US20060210533A1 (en) | Compounds and compositions for delivering active agents | |
RU2002114698A (en) | COMPOUNDS OF PHENOXICARBOXYLIC ACID AND COMPOSITIONS FOR DELIVERY OF ACTIVE SUBSTANCES | |
US9149530B2 (en) | Compositions and methods for enhancing active agent absorption | |
RU2001106603A (en) | COMPOUNDS AND COMPOSITIONS FOR DELIVERY OF ACTIVE PRODUCTS | |
RU2006140092A (en) | COMPOSITIONS AND MIXTURES FOR DELIVERY OF ACTIVE AGENTS |